tiprankstipranks
Trending News
More News >
Appili Therapeutics Inc Class A (APLIF)
OTHER OTC:APLIF
US Market

Appili Therapeutics Inc Class A (APLIF) Income Statement

Compare
82 Followers

Appili Therapeutics Inc Class A Income Statement

Last quarter (Q4 2024), Appili Therapeutics Inc Class A's total revenue was C$-12.61K, a decrease of -207.77% from the same quarter last year. In Q4, Appili Therapeutics Inc Class A's net income was C$228.05K. See Appili Therapeutics Inc Class A’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
C$ 100.44KC$ 827.41KC$ 334.18KC$ 1.39MC$ 0.00
Gross Profit
C$ 100.44KC$ 827.41KC$ 327.91KC$ 1.39MC$ -14.84K
Operating Expenses
C$ 291.28KC$ 2.92MC$ 8.11MC$ 24.95MC$ 16.28M
Depreciation and Amortization
C$ 13.46KC$ 13.66KC$ 6.27KC$ 12.64KC$ 14.84K
EBITDA
C$ 360.57KC$ -2.10MC$ -8.19MC$ -24.31MC$ -14.87M
Operating Income
C$ -190.84KC$ -2.16MC$ -7.91MC$ -24.68MC$ -16.30M
Other Income/Expenses
C$ -2.42MC$ -1.55MC$ -1.29MC$ -401.36KC$ 1.34M
Pretax Income
C$ -2.61MC$ -3.71MC$ -9.21MC$ -25.08MC$ -14.95M
Net Income
C$ -2.62MC$ -3.78MC$ -9.24MC$ -25.12MC$ -14.33M
Per Share Metrics
Basic EPS
C$ -0.02C$ -0.03C$ -0.08C$ -0.38C$ -0.24
Diluted EPS
C$ -0.02C$ -0.03C$ -0.08C$ -0.38C$ -0.24
Weighted Average Shares Outstanding
121.27M 121.27M 113.73M 66.73M 59.18M
Weighted Average Shares Outstanding (Diluted)
121.27M 121.27M 113.73M 66.73M 59.18M
Currency in CAD

Appili Therapeutics Inc Class A Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis